Drug record
What four public record sets show for lamotrigine. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.027 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $221.3 million | Details |
| FDA recall records | 13 | Details |
Whether the FDA lists this drug as in short supply.
6 products being discontinued. A maker has told the FDA it will stop making these. That is one maker leaving, not a shortage of the drug:
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Lamotrigine 25 Mg Tablet: pharmacies pay about $0.027 each, or $0.809 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| LAMOTRIGINE 100 MG TABLET | Generic | $0.048 per each | $1.45 | Oct 21, 2026 |
| LAMOTRIGINE 150 MG TABLET | Generic | $0.069 per each | $2.06 | Oct 21, 2026 |
| LAMOTRIGINE 200 MG TABLET | Generic | $0.080 per each | $2.40 | Oct 21, 2026 |
| LAMOTRIGINE 25 MG DISPER TAB | Generic | $0.150 per each | $4.51 | Oct 21, 2026 |
| LAMOTRIGINE 25 MG TABLET | Generic | $0.027 per each | $0.809 | Oct 21, 2026 |
| LAMOTRIGINE 5 MG DISPER TABLET | Generic | $0.153 per each | $4.59 | Oct 21, 2026 |
| LAMOTRIGINE ER 100 MG TABLET | Generic | $0.667 per each | $20.01 | Oct 21, 2026 |
| LAMOTRIGINE ER 200 MG TABLET | Generic | $0.648 per each | $19.45 | Oct 21, 2026 |
| LAMOTRIGINE ER 25 MG TABLET | Generic | $0.361 per each | $10.84 | Oct 21, 2026 |
| LAMOTRIGINE ER 250 MG TABLET | Generic | $1.21 per each | $36.44 | Oct 21, 2026 |
| LAMOTRIGINE ER 300 MG TABLET | Generic | $1.28 per each | $38.29 | Oct 21, 2026 |
| LAMOTRIGINE ER 50 MG TABLET | Generic | $0.551 per each | $16.54 | Oct 21, 2026 |
| LAMOTRIGINE ODT 100 MG TABLET | Generic | $1.59 per each | $47.69 | Oct 21, 2026 |
| LAMOTRIGINE ODT 200 MG TABLET | Generic | $1.79 per each | $53.56 | Oct 21, 2026 |
| LAMOTRIGINE ODT 25 MG TABLET | Generic | $1.28 per each | $38.39 | Oct 21, 2026 |
| LAMOTRIGINE ODT 50 MG TABLET | Generic | $1.33 per each | $39.75 | Oct 21, 2026 |
| LAMOTRIGINE ODT KIT (ORANGE) | Generic | $9.50 per each | $285.04 | Oct 21, 2026 |
| SUBVENITE 100 MG TABLET | Generic | $0.048 per each | $1.45 | Oct 21, 2026 |
| SUBVENITE 150 MG TABLET | Generic | $0.069 per each | $2.06 | Oct 21, 2026 |
| SUBVENITE 200 MG TABLET | Generic | $0.080 per each | $2.40 | Oct 21, 2026 |
| SUBVENITE 25 MG TABLET | Generic | $0.027 per each | $0.809 | Oct 21, 2026 |
| LAMICTAL 100 MG TABLET | Brand | $10.91 per each | $327.44 | Oct 21, 2026 |
| LAMICTAL 150 MG TABLET | Brand | $11.46 per each | $343.84 | Oct 21, 2026 |
| LAMICTAL 200 MG TABLET | Brand | $12.04 per each | $361.33 | Oct 21, 2026 |
| LAMICTAL 25 MG DISPER TABLET | Brand | $11.17 per each | $335.24 | Oct 21, 2026 |
| LAMICTAL 25 MG TABLET | Brand | $10.28 per each | $308.44 | Oct 21, 2026 |
| LAMICTAL ODT 100 MG TABLET | Brand | $14.63 per each | $438.95 | Oct 21, 2026 |
| LAMICTAL ODT 200 MG TABLET | Brand | $17.49 per each | $524.66 | Oct 21, 2026 |
| LAMICTAL ODT 25 MG TABLET | Brand | $12.81 per each | $384.27 | Oct 21, 2026 |
| LAMICTAL ODT 50 MG TABLET | Brand | $13.69 per each | $410.69 | Oct 21, 2026 |
| LAMICTAL XR 100 MG TABLET | Brand | $30.37 per each | $911.08 | Oct 21, 2026 |
| LAMICTAL XR 200 MG TABLET | Brand | $32.32 per each | $969.49 | Oct 21, 2026 |
| LAMICTAL XR 25 MG TABLET | Brand | $14.20 per each | $426.13 | Oct 21, 2026 |
| LAMICTAL XR 250 MG TABLET | Brand | $44.21 per each | $1,326.31 | Oct 21, 2026 |
| LAMICTAL XR 300 MG TABLET | Brand | $48.65 per each | $1,459.40 | Oct 21, 2026 |
| LAMICTAL XR 50 MG TABLET | Brand | $28.35 per each | $850.50 | Oct 21, 2026 |
| SUBVENITE 10 MG/ML SUSPENSION | Brand | $2.86 per mL | — | Oct 21, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $221.3 million for the 15 products below. That is down 18% from $269.2 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Lamictal Lamotrigine | $60.1 million | 5,504 | $1,381.73 | $10,918.00 | $103.3 million |
| Lamotrigine Lamotrigine | $59.2 million | 639,247 | $14.25 | $92.63 | $57.8 million |
| Lamictal XR Lamotrigine | $48.3 million | 1,884 | $3,123.97 | $25,646.71 | $47.6 million |
| Lamotrigine ER Lamotrigine | $41.3 million | 27,082 | $262.50 | $1,524.81 | $49.2 million |
| Lamotrigine ODT Lamotrigine | $9.0 million | 4,775 | $380.47 | $1,877.35 | $7.4 million |
| Lamictal ODT Lamotrigine | $3.0 million | 241 | $1,675.18 | $12,567.30 | $3.6 million |
| Lamotrigine (Orange) Lamotrigine | $226,414 | 329 | $652.49 | $688.19 | $151,198 |
| Subvenite (Orange) Lamotrigine | $49,354 | 66 | $705.05 | $747.78 | $50,128 |
| Lamotrigine (Green) Lamotrigine | $42,938 | 31 | $1,262.88 | $1,385.10 | $79,776 |
| Lamotrigine ODT (Orange) Lamotrigine | $28,621 | 82 | $332.80 | $349.04 | $15,112 |
| Lamotrigine (Blue) Lamotrigine | $26,289 | 45 | $505.56 | $584.21 | $12,055 |
| Subvenite (Green) Lamotrigine | $19,276 | 13 | $1,376.85 | $1,482.76 | — |
| Subvenite Lamotrigine | $12,346 | 220 | $15.04 | $56.12 | $31,990 |
| Subvenite (Blue) Lamotrigine | $6,972 | 14 | $464.80 | $498.00 | — |
| Lamictal (Orange) Lamotrigine | $6,227 | 13 | $415.15 | $479.02 | $28,354 |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year.
Recalls reported to the FDA that name this drug.
The FDA has 13 recall records that name lamotrigine in the product description (2 Class I · 7 Class II · 4 Class III).
Lamotrigine Tablets, USP 100 mg, 1000-count bottles, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-367-10, UPC 3 42291 36710 4
Reason: Labeling: Label Error on Declared Strength
Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC 49884-604-11 Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang 317024 China For Par Pharmaceutical Companes, Inc. Spring Valley, NY 10977 U.S.A.
Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lamotrigine Tablets, USP, 150 mg, Rx Only, a) 60 count Bottle, NDC 42291-368-60, b) 500 count Bottle, NDC 42291-368-50, Manufactured for: AvKARE, Inc. Pulaski, TN 38478.
Reason: Presence of Foreign Substance consistent with granules from desiccant packs used during storage
Lamotrigine Tablets, USP, 150 mg, 20,000-count bulk container, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, USA, For repackaging by: AvKare Inc., Pulaski, TN 38478, Bulk Shipment, NDC 59746-247-97.
Reason: Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.
Lamotrigine Tablets, USP, 100 mg, Rx Only, 100-count bottle, Mfd. by: Taro Pharmaceutical Industries Ltd. Haifa Bay, Israel 2624761 Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532, NDC 51672-4131-1.
Reason: Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT PHARMA INC., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920. NDC: 13668-342-30
Reason: Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.
Lamotrigine Orally Disintegrating Tablets (ODT), 200 mg, 30 Tablets 3 blisters containing 10 tablets each, Rx only, Manufactured by: Watson Pharma Private Ltd., Verna, Salcette Goa INDIA, Distributed by: Impax Generics, Hayward, CA
Reason: Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs
Lamotrigine Tablets, USP, 150 mg, 500-count Tablets per bottle, Rx only, Manufactured by: Unichem Laboratories LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511 India; Marketed by: Unichem Pharmaceuticals (USA), Inc ., Rochelle Park, NJ 07662; NDC 29300-113-05.
Reason: Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.
Lamotrigine Extended-Release Tablets, 25 mg Tablets, 30 Count Bottles, Rx Only. Manufactured by: Wockhardt Limited, Mumbai, India. Distributed by: Wockhardt USA LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA. NDC: 64679-271-01.
Reason: CGMP Deviations: Firm did not adequately investigate customer complaints.
Lamotrigine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Reason: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
LAMOTRIGINE TABLETS, 200 mg, 100 Tablets (10 tablets per blister card x 10 blister cards per carton), Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 51079-866-20
Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices
lamoTRIgine, Tablet, 50 mg (1/2 of 100 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 13668004701
Reason: Labeling: Label Mixup; lamotrigine, Tablet, 50 mg (1/2 of 100 mg) may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 2.5 mg (1/2 of 5 mg), NDC 00603497521, Pedigree: AD73525_64, EXP: 5/30/2014; FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: AD46257_50, EXP: 5/15/2014.
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for lamotrigine. This page is public-record information, not medical advice.